Non Hodgkin Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Biostrap arm band
  • Palo Alto, California
    Stanford University
2022-03-29
Mar 29, 2022
C
Recruiting
  • Lymphoma, Non-Hodgkin
  • +6 more
  • CB-010
  • +2 more
  • Scottsdale, Arizona
  • +5 more
2022-04-05
Apr 5, 2022
H
Recruiting
  • Primary Central Nervous System Lymphoma
  • +2 more
  • Guandong, Guangdong, China
  • +2 more
2022-04-06
Apr 6, 2022
A
K
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Goshen, Indiana
  • +39 more
2022-03-28
Mar 28, 2022
A
Active, not recruiting
  • Non Hodgkin Lymphoma
  • Tucson, Arizona
  • +32 more
2022-03-25
Mar 25, 2022
W
Enrolling by invitation
  • Breast Neoplasm
  • +5 more
  • AH-HA Tool in the EPIC EHR
  • Fort Smith, Arkansas
  • +7 more
2022-03-25
Mar 25, 2022
I
Not yet recruiting
  • Non Hodgkin Lymphoma
  • Liposomal Mitoxantrone Hydrochloride dose level 1
  • +6 more
  • (no location specified)
2022-03-17
Mar 17, 2022
S
Active, not recruiting
  • Non Hodgkin Lymphoma
  • +4 more
  • DA-EPOCH-R followed by Nivolumab
  • Antwerpen, Belgium
  • +23 more
2022-03-23
Mar 23, 2022
T
Recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • East Melbourne, Victoria, Australia
  • +7 more
2022-03-22
Mar 22, 2022
U
Active, not recruiting
  • Non Hodgkin Lymphoma
  • +8 more
  • Miami, Florida
  • +2 more
2022-03-08
Mar 8, 2022
T
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • Huntsville, Alabama
  • +16 more
2022-03-22
Mar 22, 2022
C
Suspended
  • Mediastinal Lymphoma
  • +2 more
  • Standard treatment protocol with combined chemoradiation
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
2022-03-08
Mar 8, 2022
P
Active, not recruiting
  • Multiple Myeloma
  • +3 more
  • Denver, Colorado
  • +4 more
2022-03-18
Mar 18, 2022
M
Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Total Body Irradiation
  • +4 more
  • New York, New York
    Memorial Sloan - Kettering Cancer Center
2022-03-16
Mar 16, 2022
H
Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
2022-03-14
Mar 14, 2022
C
Recruiting
  • Late Effects
  • +8 more
  • PASCA intervention
  • Lyon, France
    Centre Leon Berard
2022-03-15
Mar 15, 2022
B
Recruiting
  • Non Hodgkin Lymphoma
  • +2 more
  • Fully human anti CD19 CAR-T Cell Dose
  • +2 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
2022-03-10
Mar 10, 2022
T
Recruiting
  • Non Hodgkin Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Nanjing, Jiangsu, China
  • +1 more
2022-03-09
Mar 9, 2022
M
Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Tucson, Arizona
  • +97 more
2022-03-10
Mar 10, 2022
M
Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Zandelisib (ME-401)
  • Tucson, Arizona
  • +115 more
2022-03-08
Mar 8, 2022
U
Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2022-03-07
Mar 7, 2022